TrialBritish journal of haematology2017

Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.

Andrew J Cowan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.